ZIOPHARM Oncology Inc (ZIOP)
3.33
-0.10 -2.77%
NASDAQ
Apr 16, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.39 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -79.98M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 716.63M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 141.36 |
| PE Ratio | -- |
| Price to Book Value | 5.780 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -20.80M |
| Return on Equity | Upgrade |
View All ZIOP News
News
-
WireHeadlineTime (ET)
-
SA Breaking News04/09 09:36
-
Globe Newswire04/07 09:00
-
Yahoo03/31 16:48
-
Yahoo03/23 10:19
-
Yahoo03/12 11:43
-
SA Breaking News03/12 09:09
-
MT Newswires03/12 08:47
-
SA Breaking News03/05 15:15
-
MT Newswires03/01 09:56
-
Yahoo02/26 12:22
-
Yahoo02/26 09:30
-
Globe Newswire02/25 16:05
-
Yahoo02/25 14:30
-
SA Breaking News02/24 17:35
-
Globe Newswire02/16 16:01
-
Yahoo02/08 09:55
-
MT Newswires02/05 13:52
-
Yahoo02/05 12:00
-
Globe Newswire02/05 09:00
-
SA Breaking News01/14 10:33
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/07/2020 16:30 EDT | Earnings Calls | Q1 2020 Earnings Call |
| 05/07/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
| 06/29/2020 09:00 EDT | Agm | 2019 Annual General Meeting |
| 08/06/2020 16:30 EDT | Earnings Calls | Q2 2020 Earnings Call |
| 08/06/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 11/05/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 11/05/2020 16:30 EST | Earnings Calls | Q3 2020 Earnings Call |
| 02/25/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 02/25/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 05/07/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.
- URL: https://www.ziopharm.com
- Investor Relations URL: http://ir.ziopharm.com/index.cfm
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 25, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.33 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ZIOP Tweets Stocktwits
Advertisement
